Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status
暂无分享,去创建一个
A. Howell | D. Evans | F. Lalloo | A. Moran | R. Hartley | B. Bulman | J. Dawson | F. Knox | A. Howell | D. Evans | John Dawson | D. Evans | D. Evans
[1] E A Jones,et al. Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing , 2009, Journal of Medical Genetics.
[2] Stephanie A Cohen,et al. The prevalence of BRCA1 mutations among young women with triple-negative breast cancer , 2009, BMC Cancer.
[3] J. Marks,et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] H A Risch,et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions , 2008, British Journal of Cancer.
[5] I. Andrulis,et al. Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study , 2007, Breast Cancer Research and Treatment.
[6] Andrew Shenton,et al. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. , 2006, European journal of cancer.
[7] Julian Peto,et al. Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype , 2005, Clinical Cancer Research.
[8] N. Rahman,et al. A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO , 2004, Journal of Medical Genetics.
[9] I. Ellis,et al. Best Practice No 176 , 2004, Journal of Clinical Pathology.
[10] P. Pharoah,et al. Prediction of pathogenic mutations in patients with early-onset breast cancer by family history , 2003, The Lancet.
[11] A. Hutcheon,et al. Breast cancer in women aged 35 and under: prognosis and survival. , 2002, Journal of the Royal College of Surgeons of Edinburgh.
[12] P. Hall,et al. Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study , 2002, The Lancet.
[13] Sean V Tavtigian,et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Å. Borg,et al. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. , 2001, Journal of the National Cancer Institute.
[15] S. Seal,et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. , 1999, Journal of the National Cancer Institute.
[16] B. Ponder,et al. The Genetics of Inherited Breast Cancer , 1998, Journal of Mammary Gland Biology and Neoplasia.
[17] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[18] D. Evans,et al. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. , 1997, Cancer research.
[19] A. Bowcock,et al. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. , 1997, The New England journal of medicine.
[20] Barbara L. Smith,et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. , 1996, The New England journal of medicine.
[21] D. Neuberg,et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] A. Craft,et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. , 1994, Cancer research.
[23] B. Vogelstein,et al. Inherited p53 gene mutations in breast cancer. , 1992, Cancer research.
[24] R. Mansel,et al. The axilla: not a no-go zone , 1991, The Lancet.
[25] W. Blattner,et al. A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.
[26] W. Han,et al. Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer , 2009, Breast Cancer Research and Treatment.
[27] D. Berry,et al. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. , 1998, American journal of human genetics.